<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Merck & Co. Inc. (NYSE: MRK) announced that it had sought the Food and Drug Administration’s permission to use its investigational antiviral tablet in the treatment of mild to moderate Covid-19 adult patients on an emergency basis. The request came after phase three clinical study results, which the company released on October 1, 2021.
...read full article on Invezz
